Table 2. Characteristics of the study subjects (2013).
| All (N = 29,002) |
Category I (N = 4,177) |
Category II (N = 13,819) |
Category III (N = 8,878) |
Secondary prevention (N = 2,128) |
|
|---|---|---|---|---|---|
| Age (yr) | 64.3 ± 8.5 | 50.0 ± 6.2 | 67.3 ± 4.5 | 65.4 ± 7.9 | 68.2 ± 5.3 |
| Male (%) | 9,838 (33.9) | 740 (17.7) | 4,222 (30.6) | 3,770 (42.5) | 1,106 (52.0) |
| Body mass index (kg/m2) | 22.7 ± 3.4 | 21.9 ± 3.6 | 22.5 ± 3.2 | 23.2 ± 3.5 | 23.5 ± 3.5 |
| Waist circumference (cm) | 82.5 ± 9.6 | 79.0 ± 9.7 | 82.2 ± 9.1 | 83.9 ± 9.7 | 85.3 ± 9.6 |
| Total cholesterol (mg/dl) | 201.1 ± 33.5 | 201.9 ± 33.0 | 203.0 ± 32.1 | 200.1 ± 35.2 | 189.1 ± 33.0 |
| Triglyceride (mg/dl) | 118.5 ± 78.8 | 99.5 ± 66.0 | 114.1 ± 67.4 | 131.8 ± 95.5 | 128.4 ± 81.4 |
| HDL cholesterol (mg/dl) | 61.1 ± 15.5 | 66.6 ± 14.0 | 62.3 ± 14.3 | 57.5 ± 16.4 | 56.8 ± 15.4 |
| LDL cholesterol (mg/dl) | 120.3 ± 30.3 | 119.8 ± 31.1 | 121.8 ± 29.5 | 120.5 ± 30.9 | 111.1 ± 29.5 |
| Smoking (%) | 3,605 (12.4) | 602 (14.4) | 1,431 (10.4) | 1,299 (14.6) | 273 (12.8) |
| Suspected CKD (%) | 7,715 (26.6) | 0 (0) | 0 (0) | 6,903 (77.8) | 812 (38.2) |
| Stroke (%) | 1,349 (4.7) | 0 (0) | 0 (0) | 1,079 (12.2) | 267 (12.5) |
| Coronary artery disease (%) | 2,128 (7.3) | 0 (0) | 0 (0) | 0 (0) | 2,128 (100) |
| Hypertension (%) | 9,775 (33.7) | 416 (10.0) | 4,583 (33.2) | 3,600 (40.5) | 1,176 (55.3) |
| Diabetes (%) | 2,664 (9.2) | 0 (0) | 0 (0) | 1,024 (11.5) | 331 (15.6) |
| Lipid-lowering therapy (%) | 6,848 (23.6) | 380 (9.1) | 3,655 (26.4) | 2,157 (24.3) | 656 (30.8) |
| Hypertriglyceridemia (%) | 6,375 (22.5) | 584 (14.0) | 2,721 (19.7) | 2,513 (28.3) | 557 (26.2) |
| Low HDL cholesterolemia (%) | 1,709 (5.9) | 0 (0) | 159 (1.2) | 1,318 (14.8) | 232 (11.0) |
| Hypertriglyceridemia and low HDL cholesterolemia (%) | 1,041 (3.6) | 0 (0) | 107 (0.8) | 792 (8.9) | 142 (6.7) |
CKD: Chronic kidney disease, Hypertriglyceridemia was defined as triglyceride ≥ 150 mg/dl. Low HDL cholesterolemia was defined as HDL cholesterol <40 mg/dl